Sign in
☰
People MPsHouse of LordsGovernmentOppositionPartiesCommittees Votes Commons votesLords votesVotes by issueTopicsStats & rankingsParliament in numbers Legislation BillsEarly day motionsPetitions Elections Election resultsConstituenciesWho is my MP? Scotland OverviewMSPsScottish GovernmentVotesBillsMotionsCommitteesConstituencies & regionsElections Search Sign in

Motion · S6M-02423 · 3 Dec 2021

Ponesimod Approved by the Scottish Medicines Consortium

Lodged by Monica Lennon (Scottish Labour) Standard Motion 16 supporters

The motion

That the Parliament welcomes the news that ponesimod has been approved by the Scottish Medicines Consortium (SMC) to treat relapsing multiple sclerosis (MS); understands that this treatment option has been shown to reduce relapse rates, lessen fatigue-related symptoms and improve quality of life; notes that ponesimod is taken as a tablet orally once every day; welcomes that there are now seventeen treatments available for MS on NHS Scotland, when, 20 years ago, there were none; considers that, despite this progress, oral MS treatment options are still limited in number, and that many people with MS will benefit from this new oral option; recognises that Scotland has a high prevalence of MS; notes that the approval of ponesimod was also welcomed by the MS Society Scotland, and considers that, thanks to hard-won advancements in research, experts have never been closer to stopping MS.

Supporters (16)

Source: the Scottish Parliament motions and amendments record.